New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis
- PMID: 15737887
- DOI: 10.1016/j.beha.2004.09.004
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis
Abstract
Non-HFE haemochromatosis is a negative definition applied to all those haemochromatosis disorders that are unrelated to HFE mutations. Four genes are responsible for the distinct types of non-HFE haemochromatosis: hepcidin and hemojuvelin are the genes involved in type 2 or juvenile haemochromatosis, transferrin receptor 2 is involved in type 3 haemochromatosis, and ferroportin 1 is mutated in type 4, the atypical dominant form of primary iron overload. Molecular genetic studies of these conditions have greatly contributed to our understanding of the regulation of iron absorption. A milestone was the discovery that hepcidin, the key iron regulator in mice, is the gene mutated in the most severe, juvenile form of haemochromatosis. This finding indicates a fundamental role of hepcidin in inhibiting both iron absorption from duodenal cells and iron release from macrophages, and has opened up a new view of haemochromatosis as a disorder of hepcidin.
Similar articles
-
Non-HFE haemochromatosis.World J Gastroenterol. 2007 Sep 21;13(35):4690-8. doi: 10.3748/wjg.v13.i35.4690. World J Gastroenterol. 2007. PMID: 17729390 Free PMC article. Review.
-
Non-HFE hemochromatosis.Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316. Semin Liver Dis. 2005. PMID: 16315138 Review.
-
The molecular pathogenesis of hereditary hemochromatosis.Semin Liver Dis. 2011 Aug;31(3):280-92. doi: 10.1055/s-0031-1286059. Epub 2011 Sep 7. Semin Liver Dis. 2011. PMID: 21901658 Review.
-
HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.Natl Med J India. 2006 Jan-Feb;19(1):20-3. Natl Med J India. 2006. PMID: 16570681
-
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.Lancet. 2003 Feb 22;361(9358):669-73. doi: 10.1016/S0140-6736(03)12602-5. Lancet. 2003. PMID: 12606179
Cited by
-
Increased Retinal Expression of the Pro-Angiogenic Receptor GPR91 via BMP6 in a Mouse Model of Juvenile Hemochromatosis.Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1612-9. doi: 10.1167/iovs.15-17437. Invest Ophthalmol Vis Sci. 2016. PMID: 27046124 Free PMC article.
-
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse.Sci Rep. 2016 Aug 1;6:30725. doi: 10.1038/srep30725. Sci Rep. 2016. PMID: 27477597 Free PMC article.
-
Down-regulation of hepcidin in porphyria cutanea tarda.Blood. 2008 Dec 1;112(12):4723-8. doi: 10.1182/blood-2008-02-138222. Epub 2008 Sep 22. Blood. 2008. PMID: 18809758 Free PMC article.
-
Guest editorial: the seven wonders of erythropoiesis.Int J Hematol. 2011 Jan;93(1):1-4. doi: 10.1007/s12185-010-0762-y. Epub 2011 Jan 12. Int J Hematol. 2011. PMID: 21222183 No abstract available.
-
Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.Toxicol Appl Pharmacol. 2017 Apr 15;321:1-17. doi: 10.1016/j.taap.2017.02.006. Epub 2017 Feb 16. Toxicol Appl Pharmacol. 2017. PMID: 28213091 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical